Search research articles
Contact Us
Filters
Showing results (81-90 of 124) with videos related to
Page
of 13
Sort By:
Molecular and Cellular Biology
|
March 1, 2018
Retraction for Melillo et al., "Critical Role of the HMGI(Y) Proteins in Adipocytic Cell Growth and Differentiation"
Rosa Marina Melillo, Giovanna Maria Pierantoni, Stefania Scala, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 6, 2018
Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity
Anna Maria Trotta, Sara Santagata, Serena Zanotta, et al.
Oncology
|
January 6, 2016
Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy
Alessandro Ottaiano, Anna Nappi, Salvatore Tafuto, et al.
Plos One
|
September 24, 2013
Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastases
Luigi Portella, Rosamaria Vitale, Stefania De Luca, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 8, 2021
PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2/Ras/MAPK signalling in thyroid cancer cells
Federica Liotti, Narender Kumar, Nella Prevete, et al.
Hepatology International
|
May 4, 2023
Hepatocellular carcinoma (HCC) tumor microenvironment is more suppressive than colorectal cancer liver metastasis (CRLM) tumor microenvironment
Sara Santagata, Giuseppina Rea, Daniela Castaldo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 23, 2022
Olaparib beyond progression compared with platinum chemotherapy after secondary cytoreductive surgery in patients with recurrent ovarian cancer: phase III randomized, open-label MITO 35b study, a project of the MITO-MANGO groups
Clorinda Schettino, Lucia Musacchio, Michele Bartoletti, et al.
Nanoscale
|
March 18, 2016
CXCR4-antagonist Peptide R-liposomes for combined therapy against lung metastasis
Caterina Ieranò, Luigi Portella, Sara Lusa, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
July 1, 2020
Disulfide Bond Replacement with 1,4- and 1,5-Disubstituted [1,2,3]-Triazole on C-X-C Chemokine Receptor Type 4 (CXCR4) Peptide Ligands: Small Changes that Make Big Differences
Stefano Tomassi, Anna Maria Trotta, Caterina Ieranò, et al.
Bioorganic & Medicinal Chemistry
|
April 17, 2018
Cationic nucleopeptides as novel non-covalent carriers for the delivery of peptide nucleic acid (PNA) and RNA oligomers
Stefano Tomassi, Caterina Ieranò, Maria Emilia Mercurio, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 124) with videos related to
Sort By:
Page
of 13
Molecular and Cellular Biology
|
March 1, 2018
Retraction for Melillo et al., "Critical Role of the HMGI(Y) Proteins in Adipocytic Cell Growth and Differentiation"
Rosa Marina Melillo, Giovanna Maria Pierantoni, Stefania Scala, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 6, 2018
Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity
Anna Maria Trotta, Sara Santagata, Serena Zanotta, et al.
Oncology
|
January 6, 2016
Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy
Alessandro Ottaiano, Anna Nappi, Salvatore Tafuto, et al.
Plos One
|
September 24, 2013
Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastases
Luigi Portella, Rosamaria Vitale, Stefania De Luca, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 8, 2021
PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2/Ras/MAPK signalling in thyroid cancer cells
Federica Liotti, Narender Kumar, Nella Prevete, et al.
Hepatology International
|
May 4, 2023
Hepatocellular carcinoma (HCC) tumor microenvironment is more suppressive than colorectal cancer liver metastasis (CRLM) tumor microenvironment
Sara Santagata, Giuseppina Rea, Daniela Castaldo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 23, 2022
Olaparib beyond progression compared with platinum chemotherapy after secondary cytoreductive surgery in patients with recurrent ovarian cancer: phase III randomized, open-label MITO 35b study, a project of the MITO-MANGO groups
Clorinda Schettino, Lucia Musacchio, Michele Bartoletti, et al.
Nanoscale
|
March 18, 2016
CXCR4-antagonist Peptide R-liposomes for combined therapy against lung metastasis
Caterina Ieranò, Luigi Portella, Sara Lusa, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
July 1, 2020
Disulfide Bond Replacement with 1,4- and 1,5-Disubstituted [1,2,3]-Triazole on C-X-C Chemokine Receptor Type 4 (CXCR4) Peptide Ligands: Small Changes that Make Big Differences
Stefano Tomassi, Anna Maria Trotta, Caterina Ieranò, et al.
Bioorganic & Medicinal Chemistry
|
April 17, 2018
Cationic nucleopeptides as novel non-covalent carriers for the delivery of peptide nucleic acid (PNA) and RNA oligomers
Stefano Tomassi, Caterina Ieranò, Maria Emilia Mercurio, et al.
Page
of 13